Director Mary Tagliaferri resigns from Enzo Biochem board, effective Aug 6, 2024

ENZO BIOCHEM INC

Mary Tagliaferri, M.D., resigned from the Board, effective August 6, 2024, to pursue other opportunities.
Resignation was not due to any disagreement with the Company on operations, policies, or practices.
Company has commenced a search for a replacement director to fill the vacancy.
Board expressed gratitude for Dr. Tagliaferri's service and contributions.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Mary Tagliaferri

Director

ENZO BIOCHEM INC

Effective: 2024-08-06
Filed: August 2, 2024, 7:59 PM ET

On July 29, 2024, Mary Tagliaferri, M.D., informed the Board of Directors (the “Board”) of Enzo Biochem, Inc. (the “Company”) of her resignation as a member of the Board, effective August 6, 2024, to pursue other opportunities.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mary Tagliaferri resigned as Director at ENZO BIOCHEM INC.

Action: resigned
Role: Director

Exact text from the filing

On July 29, 2024, Mary Tagliaferri, M.D., informed the Board of Directors (the “Board”) of Enzo Biochem, Inc. (the “Company”) of her resignation as a member of the Board, effective August 6, 2024, to pursue other opportunities.

View on SEC.gov

Source: SEC EDGAR

accession 0001213900-24-064752

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.